Search

everythinglearnresearchcommunity

for

Search:↓

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

Hair loss in women linked to higher sexual dysfunction risk.

Men with prediabetes have worse sexual health and a higher risk of severe erectile dysfunction.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Finasteride does not cause sexual dysfunction in men with hair loss.

Female pattern hair loss does not significantly affect sexual dysfunction.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Men may experience long-term sexual dysfunction after stopping Finasteride.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Certain medications can reduce sexual desire and function, especially in women.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Flibanserin shows promise for treating male sexual dysfunction but has side effects like insomnia and fatigue.

Finasteride for hair loss may cause long-lasting sexual side effects in young males.

Finasteride use doesn't cause sexual dysfunction in men with hair loss.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Many different biological, psychological, and social factors can cause sexual dysfunction in American women.

Finasteride, a hair loss treatment, may cause long-term sexual dysfunction and depression.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Knowing about finasteride's sexual side effects increases reported dysfunction.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.